Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

Kozlitina, Julia, Smagris, Eriks, Stender, Stefan, Nordestgaard, Børge G, Zhou, Heather H, Tybjærg-Hansen, Anne, Vogt, Thomas F, Hobbs, Helen H +1 more·2014·Nature Genetics

DOI 10.1038/ng.2901

Cited by (1,001)

Items 101–200 of 1,001

Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
Stefano Romeo, Arun Jayant Sanyal, Luca V. C. Valenti · 2020 · Cell Metabolism
The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background
Yu, Jinsheng, Marsh, Sharon, Hu, Junbo, Feng, Wenke, Wu, Chaodong · 2016 · Gastroenterology Research and Practice
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, Hirofumi Uto, Masafumi Ono, Yoshio Sumida, Masataka Seike, Yoshiyuki Takei, Tetsuo Takehara, Katsutoshi Tokushige et al. · 2015 · Hepatology Research
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
José María Mato, Cristina Alonso, Mazen Noureddin, Shelly Chi-Loo Lu · 2019 · World Journal of Gastroenterology
Nonalcoholic fatty liver disease: Evolving paradigms
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, Alessandra Marrazzo, Luca Rinaldi, Luigi Elio Adinolfi · 2017 · World Journal of Gastroenterology
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
Simona Marchisello, Antonino Di Pino, Roberto Scicali, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Maria Rabuazzo · 2019 · International Journal of Molecular Sciences
Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
Claudio Tana, Stefano Ballestri, Fabrizio Ricci, Angelo Di Vincenzo, Andrea Ticinesi, Sabina Gallina, Maria Adele Giamberardino, Francesco Cipollone, Richard Sutton, Roberto Vettor et al. · 2019 · International Journal of Environmental Research and Public Health
Hepatic lipid droplet homeostasis and fatty liver disease
Fabian Seebacher, Anja Zeigerer, Nora Kory, Natalie Krahmer · 2020 · Seminars in Cell and Developmental Biology
Improved diet quality associates with reduction in liver fat, particularly in individuals with high genetic risk scores for nonalcoholic fatty liver disease
Ma, Jiantao, Hennein, Rachel, Liu, Chunyu, Long, Michelle T., Hoffmann, Udo, Jacques, Paul F., Lichtenstein, Alice H., Hu, Frank B., Levy, Daniel · 2018 · Gastroenterology
Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations
Zaki A. Sherif, Armana Saeed, Shima Ghavimi, Mehdi syed Nouraie, Adeyinka O. Laiyemo, Hassan Brim, Hassan Ashktorab · 2016 · Digestive Diseases and Sciences
The landscape of gene mutations in cirrhosis and hepatocellular carcinoma
Miryam Müller, Thomas Graham Bird, Jean‐Charles Nault · 2020 · Journal of Hepatology
Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
Youn Huh, Yoon Jeong Cho, Ga Eun Nam · 2022 · Journal of Obesity & Metabolic Syndrome
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
Laursen, Tea L, Hagemann, Christoffer A, Wei, Chunshan, Kazankov, Konstantin, Thomsen, Karen L, Knop, Filip K, Grønbæk, Henning · 2019 · World Journal of Hepatology
Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis
Carlsson, Björn, Lindén, Daniel, Brolén, Gabriella, Liljeblad, Mathias, Bjursell, Mikael, Romeo, Stefano, Loomba, Rohit · 2020 · Alimentary Pharmacology & Therapeutics
The dual and opposite role of the TM6SF2‐rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta‐analysis
Carlos Jose Pirola, Silvia C. Sookoian · 2015 · Hepatology
Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, Maria Vittoria Morone, Chiara Silvestri, Mauro Giordano, Teresa Salvatore, Ferdinando Carlo Sasso · 2021 · Antioxidants
Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
Valenti, Luca, Bugianesi, Elisabetta, Pajvani, Utpal, Targher, Giovanni · 2016 · Liver International
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
Luukkonen, Panu K., Qadri, Sami, Ahlholm, Noora, Porthan, Kimmo, Männistö, Ville, Sammalkorpi, Henna, Penttilä, Anne K., Hakkarainen, Antti, Lehtimäki, Tiina E., Gaggini, Melania et al. · 2022 · Journal of Hepatology
Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Veeral H. Ajmera, Charlie C. Park, Cyrielle Caussy, Seema Singh, Carolyn Hernandez, Ricki Bettencourt, Jonathan C. Hooker, Ethan Z. Sy, Cynthia A. Behling, Ronghui Xu et al. · 2018 · Gastroenterology
The genetics of alcohol dependence and alcohol-related liver disease
Felix Stickel, Christophe Moreno, Jochen Hampe, Marsha Yvonne Morgan · 2016 · Journal of Hepatology
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
Giovanni Targher, Kathleen E. Corey, Christopher D. Byrne · 2020 · Diabetes & Metabolism
The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
Nikolaos Perakakis, Konstantinos Stefanakis, Christos Socrates Mantzoros · 2020 · Metabolism
The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
Christopher Paul Day, Quentin Mark Anstee · 2015 · Seminars in Liver Disease
Improved Ancestry Estimation for both Genotyping and Sequencing Data using Projection Procrustes Analysis and Genotype Imputation
Chaolong Wang, Xiaowei Zhan, Liming Liang, Gonçalo R. Abecasis, Xihong Lin · 2015 · The American Journal of Human Genetics
A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease
Connor A. Emdin, Mary E. Haas, Amit V. Khera, Krishna G. Aragam, Mark D. Chaffin, Derek M. Klarin, George Hindy, Lan Jiang, Wei‐Qi Wei, QiPing Feng et al. · 2020 · PLoS Genetics
The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease
Marie Boyle, Steven Masson, Quentin Mark Anstee · 2017 · Journal of Hepatology
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, Shuang, Friedman, Scott L. · 2023 · Science Translational Medicine
Metabolic liver disease in diabetes – From mechanisms to clinical trials
Bedair Dewidar, SABINE KAHL, Kalliopi Pafili, Michael Roden · 2020 · Metabolism
Genetic and epigenetic factors determining NAFLD risk
Wenke Jonas, Annette Schürmann · 2020 · Molecular Metabolism
Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants
Clémence Rives, Anne Fougerat, Sandrine Ellero‐Simatos, Nicolas Loiseau, Hervé Guillou, Laurence Gamet‐Payrastre, Walter Wahli · 2020 · Biomolecules
Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment
Paloma Sangro, Manuel de la Torre‐Aláez, Bruno Sangro, Delia D’Avola · 2023 · Journal of Physiology and Biochemistry
Integration of Multi-omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-Alcoholic Fatty Liver Disease
Karthickeyan Chella Krishnan, Zeyneb Kurt, Rio Barrere‐Cain, Simon Sabir, Aditi Das, Raquel R. Floyd, Laurent Vergnes, Yuqi Zhao, Nam Che, Sarada Charugundla et al. · 2018 · Cell Systems
Nonalcoholic Fatty Liver Disease in Children
Jake Peter Mann, Luca V. C. Valenti, Eleonora Scorletti, Christopher D. Byrne, Valério Nobili · 2018 · Seminars in Liver Disease
Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
Hannele Yki‐Järvinen · 2015 · Nutrients
Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
Martijn C.G.J. Brouwers, Nynke Simons, Coen D.A. Stehouwer, Aaron J. Isaacs · 2019 · Diabetologia
Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
Paola Dongiovanni, Stefano Romeo, Luca V. C. Valenti · 2015 · BioMed Research International
Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression
Nisreen A. Nimer, Ibrahim Choucair, Zeneng Wang, Ina Nemet, Lin Li, Janet Gukasyan, Taylor L. Weeks, Naim Alkhouri, Nizar N. Zein, W.H. Wilson Tang et al. · 2020 · Metabolism
Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis
Xianbo Zuo, Liangdan Sun, Xianyong Yin, Jinping Gao, Yujun Sheng, Jinhua Xu, Jianzhong Zhang, Chundi He, Ying Qiu, Guangdong Wen et al. · 2015 · Nature Communications
Mitochondria-rough-ER contacts in the liver regulate systemic lipid homeostasis
Irene Anastasia, Nicolò Ilacqua, Andrea Raimondi, Philippe Lemieux, Rana Ghandehari‐Alavijeh, Guilhem Faure, Sergei Mekhedov, Kevin J. Williams, Federico Caicci, Giorgio Valle et al. · 2021 · Cell Reports
Exome-wide association study on alanine aminotransferase identifies sequence variants in the GPAM and APOE associated with fatty liver disease
Jamialahmadi, Oveis, Mancina, Rosellina Margherita, Ciociola, Ester, Tavaglione, Federica, Luukkonen, Panu K., Baselli, Guido, Malvestiti, Francesco, Thuillier, Dorothée, Raverdy, Violeta, Männistö, Ville et al. · 2021 · Gastroenterology
TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease
Fei Luo, Federico Oldoni, Avash Das · 2021 · Hepatology Communications
Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
José Antonio Del Campo, Rocío Gallego‐Durán, Paloma Gallego, Lourdes Grande · 2018 · International Journal of Molecular Sciences
History of Nonalcoholic Fatty Liver Disease
Amedeo Lonardo, Simona Leoni, Khalid Alswat, Yasser Mahrous Fouad · 2020 · International Journal of Molecular Sciences
Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD—A Systematic Review
Elina M. Petäjä, Hannele Yki‐Järvinen · 2016 · International Journal of Molecular Sciences
Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers
Takahisa Kawaguchi, Toshihide Shima, Masayuki Mizuno, Yasuhide Mitsumoto, Atsushi Umemura, Yoshihiro Kanbara, Saiyu Tanaka, Yoshio Sumida, Kohichiro Yasui, Meiko Takahashi et al. · 2018 · PLoS ONE
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome
Patrick Wainwright, Christopher D. Byrne · 2016 · International Journal of Molecular Sciences
Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease
Carlos Jose Pirola, Martin E. Garaycoechea, Diego Martin Flichman, Marco A. Arrese, Julio San Martino, Carla Gazzi, Gustavo Osvaldo Castaño, Silvia C. Sookoian · 2018 · Journal of Lipid Research
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
Anne Fougerat, Alexandra Montagner, Nicolas Loiseau, Hervé Guillou, Walter Wahli · 2020 · Cells
Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options
Piero Portincasa, Mohamad Khalil, Laura Mahdi, Valeria Perniola, Valeria Idone, Annarita Graziani, György Baffy, Agostino Di Ciaula · 2024 · International Journal of Molecular Sciences
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
Katsutoshi Tokushige, Kenichi Ikejima, Masafumi Ono, Yuichiro Eguchi, Yoshihiro Kamada, Yoshito Itoh, Norio Akuta, Masato Yoneda, Motoh Iwasa, Masashi Yoneda et al. · 2021 · Hepatology Research
Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation
Neda Yahoo, Michael Dudek, Percy Alexander Knolle, Mathias F Heikenwälder · 2023 · Journal of Hepatology
Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study
Martina Goffredo, Sonia Caprio, Ariel E. Feldstein, Ebe D’Adamo, Melissa M. Shaw, Bridget M. Pierpont, Mary Savoye, Hongyu Zhao, Allen E. Bale, Nicola Santoro · 2015 · Hepatology
Non-alcoholic fatty liver disease and risk of type 2 diabetes
Susanna Lallukka, Hannele Yki‐Järvinen · 2016 · Best Practice & Research Clinical Endocrinology & Metabolism
Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review
Ajmera, Veeral H., Terrault, Norah A., Harrison, Stephen A. · 2017 · Hepatology
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
Umair Iqbal, Brandon J. Perumpail, Daud H. Akhtar, Donghee Kim, Aijaz Ahmed · 2019 · Medicines
NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects
Eeva Sliz, Sylvain P Sebert, Peter Würtz, Antti J. Kangas, Pasi Soininen, Terho J. Lehtimäki, Mika A. P. Kähönen, Jorma S.A. Viikari, Minna Männikkö, Mika Ala‐Korpela et al. · 2018 · Human Molecular Genetics
NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment
Mingfeng Xia, Hua Bian, Xin Gao · 2019 · Frontiers in Pharmacology
Influence of Dietary Macronutrients on Liver Fat Accumulation and Metabolism
Sion A. Parry, Leanne Hodson · 2017 · Journal of Investigative Medicine
PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases
Jie Yang, Eric Trépo, Pierre Nahon, Qian Cao, Christophe Moreno, Éric Letouzé, Sandrine Imbeaud, Thierry Gustot, Jacques M.E. Deviere, Stéphanie Debette et al. · 2018 · International Journal of Cancer
In Vitro Models for Non-Alcoholic Fatty Liver Disease: Emerging Platforms and Their Applications
Ramos, Maria Jimenez, Bandiera, Lucia, Menolascina, Filippo, Fallowfield, Jonathan Andrew · 2022 · iScience
Liver Function and Risk of Type 2 Diabetes: Bidirectional Mendelian Randomization Study
N. Maneka G. De Silva, Maria Carolina Borges, Aroon Dinesh Hingorani, Jorgen Engmann, Tina Shah, Xiaoshuai Zhang, Jian’an Luan, Claudia Langenberg, Andrew Wong, Diana J. Kuh et al. · 2019 · Diabetes
Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology
Silvia C. Sookoian, Carlos Jose Pirola, Luca V. C. Valenti, Nicholas O. Davidson · 2020 · Hepatology
Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene–Environment Interaction Study
Connor A. Emdin, Mary Haas, Veeral H. Ajmera, Tracey G. Simon, Julian R. Homburger, Cynthia L. Neben, Lan Jiang, Wei‐Qi Wei, QiPing Feng, Alicia Yiran Zhou et al. · 2020 · Gastroenterology
Germline Mutations in <i>CIDEB</i> and Protection against Liver Disease
Verweij, Niek, Haas, Mary E., Nielsen, Jonas B., Sosina, Olukayode A., Kim, Minhee, Akbari, Parsa, De, Tanima, Hindy, George, Bovijn, Jonas, Persaud, Trikaldarshi et al. · 2022 · New England Journal of Medicine
Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD
Panu K. Luukkonen, You Zhou, P.A. Nidhina Haridas, Om Prakash Dwivedi, Tuulia Hyötyläinen, Ashfaq Ali, Anne Juuti, Marja Leivonen, Taru Tukiainen, Linda L. Ahonen et al. · 2017 · Journal of Hepatology
Risk stratification and early detection biomarkers for precision HCC screening
Yi‐Te Lee, Naoto Fujiwara, Ju Dong Yang, Yujin Hoshida · 2022 · Hepatology
Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research
Christina‐Maria Flessa, Narjes Nasiri Ansari, Ioannis Kyrou, Bianca Maria Leca, Maria Lianou, Antonios Chatzigeorgiou, Gregory Kaltsas, Eva N. Kassi, Harpal Singh Randeva · 2022 · International Journal of Molecular Sciences
Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality
Mara Sophie Vell, Rohit Seth Loomba, Arunkumar Krishnan, Kirk J. Wangensteen, Jonel Trebicka, Kate Townsend Creasy, Christian Trautwein, Eleonora Scorletti, Katharina Sophie Seeling, Leonida Hehl et al. · 2023 · JAMA Network Open
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids
Sebastian Prill, Andrea Marco Caddeo, Guido Baselli, Oveis Jamialahmadi, Paola Dongiovanni, Raffaela Rametta, Kajsa P. Kanebratt, Arturo Pujia, Piero Pingitore, Rosellina Margherita Mancina et al. · 2019 · Scientific Reports
Nutrition and Genetics in NAFLD: The Perfect Binomium
Marica Meroni, Miriam Longo, Alice Rustichelli, Paola Dongiovanni · 2020 · International Journal of Molecular Sciences
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes
Mohammed Eslam, Alessandra Mangia, Thomas Berg, Henry Lik‐Yuen Chan, William Lucien Irving, Gregory J. Dore, Maria Lorena Abate, Elisabetta Bugianesi, Leon Anton Adams, Mustafa A. Najim et al. · 2016 · Hepatology
Relationship between NAFLD and coronary artery disease: A Mendelian randomization study
Zhewen Ren, Pomme I. H. G. Simons, Anke Wesselius, Coen D.A. Stehouwer, Martijn C.G.J. Brouwers · 2022 · Hepatology
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage
Benedetta Donati, Benedetta Maria Motta, Piero Pingitore, Marica Meroni, Alessandro Pietrelli, Anna Alisi, Salvatore Petta, Chao Xing, Paola Dongiovanni, Benedetta Del Menico et al. · 2015 · Hepatology
Phosphatase-like Activity of Porous Nanorods of CeO 2 for the Highly Stabilized Dephosphorylation under Interferences
Tianzhu Yao, Zhimin Tian, Yinqing Zhang, Yongquan Qu · 2018 · ACS Applied Materials & Interfaces
Non‐alcoholic fatty liver disease‐related risk of cardiovascular disease and other cardiac complications
Christopher D. Byrne, Giovanni Targher · 2021 · Diabetes Obesity and Metabolism
Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD
Mary Eugenia Rinella, Frank Tacke, Arun Jayant Sanyal, Quentin Mark Anstee, on behalf of the participants of the AASLD/EASL Workshop · 2019 · Hepatology
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis
Felix Stickel, Stephan Buch, Hans Dieter Nischalke, Karl Heinz Weiss, Daniel Nils Gotthardt, Janett Fischer, Jonas Rosendahl, Astrid Marot, Mona Elamly, Markus Casper et al. · 2018 · The American Journal of Gastroenterology
NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?
Daniela Stols‐Gonçalves, G. Kees Hovingh, Max Nieuwdorp, Adriaan Georgius Holleboom · 2019 · Trends in Endocrinology and Metabolism
Machine learning enables new insights into genetic contributions to liver fat accumulation
Haas, Mary E., Pirruccello, James P., Friedman, Samuel N., Wang, Minxian, Emdin, Connor A., Ajmera, Veeral H., Simon, Tracey G., Homburger, Julian R., Guo, Xiuqing, Budoff, Matthew et al. · 2021 · Cell Genomics
Genetics of nonalcoholic fatty liver disease
Paola Dongiovanni, Luca V. C. Valenti · 2015 · Metabolism
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
Raul Dias Santos, Luca V. C. Valenti, Stefano Romeo · 2019 · Atherosclerosis
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
Grazia Raffaella Tundo, Diego Sbardella, Anna Maria Santoro, Andrea Coletta, Francesco Oddone, Giuseppe Grasso, Danilo Milardi, Pedro Miguel Lacal, Stefano Marini, Roberto Purrello et al. · 2020 · Pharmacology & Therapeutics
Receptor-Mediated ER Export of Lipoproteins Controls Lipid Homeostasis in Mice and Humans
Xiao Wang, Huimin Wang, Bolin Xu, Dong Huang, Chao Nie, Longjun Pu, Gregory J. M. Zajac, Han Yan, Jingru Zhao, Fangyuan Shi et al. · 2020 · Cell Metabolism
Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese
Clara Sze-Man Tang, He Zhang, Chloe Y. Y. Cheung, Ming Xu, Jenny Chung-Yee Ho, Wei Zhou, Stacey Shawn Cherny, Yan Zhang, Oddgeir L. Holmen, Ka‐Wing Au et al. · 2015 · Nature Communications
Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota
Michael Doulberis, Georgios Kotronis, Dimitra Gialamprinou, Jannis Kountouras, Panagiotis Katsinelos · 2017 · Metabolism
Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending?
Miriam Longo, Marica Meroni, Erika Paolini, Chiara Macchi, Paola Dongiovanni · 2021 · Metabolism
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models
Miriam Longo, Marica Meroni, Erika Paolini, Veronica Erconi, Fabrizia Carli, Francesco Fortunato, Dario Ronchi, Roberto Piciotti, Silvia Sabatini, Chiara Macchi et al. · 2021 · Cellular and Molecular Gastroenterology and Hepatology
Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2
You Zhou, Gemma Llauradó, Matej Orešič, Tuulia Hyötyläinen, Marju Orho‐Melander, Hannele Yki‐Järvinen · 2014 · Journal of Hepatology
Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond
Marcin Jan Krawczyk, Roman Liebe, Frank Lammert · 2020 · Gastroenterology
Patatin-like phospholipase domain–containing protein 3 promotes transfers of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets
Matthew A. Mitsche, Helen H. Hobbs, Jonathan C. Cohen · 2018 · Journal of Biological Chemistry
Liver‐Specific Deletion of Mouse Tm6sf2 Promotes Steatosis, Fibrosis, and Hepatocellular Cancer
Elizabeth P. Newberry, Zoe Hall, Yan Xie, Elizabeth A. Molitor, Peter O. Bayguinov, Gregory W. Strout, James A. J. Fitzpatrick, Elizabeth M. Brunt, Julian Leether Griffin, Nicholas O. Davidson · 2021 · Hepatology
Additive effects of PNPLA3 and TM6SF2 on the histological severity of non‐alcoholic fatty liver disease
Bo Kyung Koo, Sae Kyung Joo, Donghee Kim, Jeong Mo Bae, Jeong Hwan Park, Jung Ho Kim, Won Kyum Kim · 2017 · Journal of Gastroenterology and Hepatology
Genetic and Epigenetic Modifiers of Alcoholic Liver Disease
Marica Meroni, Miriam Longo, Raffaela Rametta, Paola Dongiovanni · 2018 · International Journal of Molecular Sciences
A 17‐Beta‐Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease
Jie Yang, Eric Trépo, Pierre Nahon, Qian Cao, Christophe Moreno, Éric Letouzé, Sandrine Imbeaud, Quentin Bayard, Thierry Gustot, Jacques M.E. Deviere et al. · 2019 · Hepatology
MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy
Yingxin Xian, Jianping Weng, Fen Liang Xu · 2020 · Chinese Medical Journal
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications
Rossella Palma, Annamaria Pronio, Mario Romeo, Flavia Scognamiglio, Lorenzo Ventriglia, Vittorio Maria Ormando, Antonietta Lamazza, Stefano Pontone, Alessandro Federico, Marcello Dallio · 2022 · Journal of Clinical Medicine
Nonalcoholic fatty liver disease – current status and future directions
Demir, Münevver, Lang, Sonja, Steffen, Hans‐Michael · 2015 · Journal of Digestive Diseases
Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review
Tyler J Severson, Siddesh V. Besur, Herbert L. Bonkovsky · 2016 · World Journal of Gastroenterology
The genetic architecture of NAFLD among inbred strains of mice
Simon T. Y. Hui, Brian W. Parks, Elin Org, Frode Norheim, Nam Che, Calvin Pan, Lawrence W. Castellani, Sarada Charugundla, Darwin L Dirks, Nikolaos Psychogios et al. · 2015 · eLife
Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma
Özlem Kutlu, Hümeyra Nur Kaleli, Ebru Ozer · 2018 · Canadian Journal of Gastroenterology and Hepatology